Neuropilin-1 (NRP1) is a cell-surface receptor for both vascular endothelial growth factor 165 (VEGF165) and class 3 semaphorins that is expressed by neurons and endothelial cells. NRP1 is required for normal developmental angiogenesis in mice. The zebrafish is an excellent system for analyzing vascular development. Zebrafish intersegmental vessels correspond to mammalian capillary sprouts, whereas the axial vessels correspond to larger blood vessels, such as arteries. The zebrafish NRP1 gene (znrp1) was isolated and when overexpressed in cells, zNRP1 protein was a functional receptor for human VEGF 165. Whole-mount in situ hybridization showed that transcripts for znrp1 during embryonic and early larval development were detected mainly in neuronal and vascular tissues. Morpholino-mediated knockdown of zNRP1 in embryos resulted in vascular defects, most notably impaired circulation in the intersegmental vessels. Circulation via trunk axial vessels was not affected. Embryos treated with VEGF receptor-2 kinase inhibitor had a similar intersegmental vessel defect suggesting that knockdown of zNRP1 reduces VEGF activity. To determine whether NRP1 and VEGF activities were interdependent in vivo, zNRP1 and VEGF morpholinos were coinjected into embryos at concentrations that individually did not significantly inhibit blood vessel development. The result was a potent inhibition of blood cell circulation via both intersegmental and axial vessels demonstrating that VEGF and NRP1 act synergistically to promote a functional circulatory system. These results provide the first physiological demonstration that NRP1 regulates angiogenesis through a VEGF-dependent pathway.
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receptor kinase inhibitor ͉ vasculogenesis ͉ semaphorins ͉ antisense morpholino N europilin (NRP) is a 130-to 140-kDa membrane glycoprotein first identified in the optic tectum of Xenopus laevis and subsequently in the developing brain (1) . Currently, there are two known nrp genes designated as nrp1 and nrp2 (2) (3) (4) . NRP1 localizes to axons and was first identified as the receptor for Sema3A, a secreted axon guidance molecule that repels axons and collapses growth cones of dorsal root ganglia (3, 5) . Recently, we identified NRP1 as a functional receptor for VEGF 165 (6) , a potent angiogenesis factor essential for normal developmental angiogenesis (7, 8) and tumor angiogenesis (9) . NRPs are the second class of VEGF receptors (VEGFRs) described so far, after the three receptor tyrosine kinases, VEGFR-1, VEGFR-2, and VEGFR-3 (10, 11) . NRPs do not appear to be receptor kinases but may act as coreceptors for VEGFR-2 that enhance VEGF 165 activity (6) .
There is ample evidence to suggest that NRP1 is involved in normal mouse vascular development as well as pathological angiogenesis, although the mechanism is unclear. It is expressed abundantly in endothelial cells (EC) of developing embryonic blood vessels (12) . NRP1 knockout mice display abnormal axonal networks, deficiencies in neuronal vascularization, aortic arch malformations, and diminished and disorganized yolk sac vascularization (13, 14) . Conversely, overexpression of NRP1 during mouse development results in excessive and abnormal blood vessel formation throughout the embryo (12) . NRP1 is highly expressed by certain tumor cell types as the only VEGFR and contributes to tumor angiogenesis (6, 15) . Conditional expression of NRP1 in tumor cells resulted in larger and more vascular tumors, possibly because of the increased concentration of NRP1-bound VEGF in the tumor.
To gain new insights into the function of NRPs in blood vessel development, we decided to study the vascular function of NRP in zebrafish. The zebrafish vascular system is advantageous for study because of the transparency of the embryos and the rapid development of a functional circulatory system (16) . Functional analysis is facilitated by the ability to readily introduce small compounds into embryos to antagonize protein function-e.g., antisense morpholino oligonucleotides that specifically blocks a protein's translation (17) and VEGFR-2 kinase inhibitors that inhibit VEGF activity (18) . Embryos treated with antisense morpholinos targeting VEGF showed a marked loss of developing blood vessels during vascular development (19) .
Although NRP1 binds VEGF 165 in vitro and NRP1 is clearly required for mouse developmental angiogenesis, a question not yet resolved is whether VEGF activity depends on interactions with NRPs in vivo. We report here the cloning of the znrp1 gene, its expression in development, and its functional characterization. Embryos microinjected with zNRP1 antisense morpholino oligonucleotides exhibited vascular defects including impaired circulation in the intersegmental vessels whereas circulation via trunk axial vessels was not affected. Coinjection of zNRP1 and zebrafish VEGF morpholinos at concentrations that individually did not inhibit blood vessel development significantly yielded a severe aberrant vascular phenotype including loss of both trunk axial and intersegmental vessel circulation. These results demonstrate that zebrafish VEGF activity is zNRP1 dependent. The results also provide a mechanism for the angiogenic properties of NRP1.
Materials and Methods
Zebrafish Maintenance. Zebrafish (Danio rerio) were maintained in the Children's Hospital breeding colony at 28.5°C on a 14 hr light͞10 hr dark cycle. Embryos were collected from the natural mating of breeding pairs (AB), raised at 28.5°C, and staged as described (20) . When necessary, embryos were anesthetized with 0.003% tricaine (Sigma). Embryos older than 24 h postfertilization (hpf) were raised in 0.2 mM 1-phenyl-2-thio-urea (Sigma) to prevent pigment formation.
Cloning of Full-Length Zebrafish NRP1 cDNA. Degenerate PCR.
Degenerate primers for NRP1 were made based on highly conserved amino acid sequences from rat, chicken, mouse, and human NRP1 (GIBCO). The forward primer was generated based on a consensus amino acid sequence DRLEIWD found in the NRP1 a domain (amino acids 208-214 of human NRP1). The reverse primer was generated based on a consensus amino acid sequence DECDDDQ found in the NRP1 c domain (amino acids 601-607 of human NRP1). An inosine residue was used at nucleotide positions where complete degeneracy was required. The forward primer sequence was 5Ј-GA(C͞T)(A͞C)GI(C͞T)TIGA(A͞G)ATIT-GGGA-3Ј. The reverse primer sequence was 5Ј-TG(A͞G)TC (A͞G)TC(A͞G)TC(A͞G)CA(C͞T)TC(A͞G)TC-3Ј. A PCR product Ϸ1.2 kb in size was cloned into the pGEM-T-easy vector (Promega) and sequenced.
5Ј-and 3Ј-rapid amplification of cDNA ends (RACE). Further 5Ј-and 3Ј-zebrafish NRP1 cDNA sequences were obtained by reverse transcription-PCR from 24 hpf embryo total RNA by using the SMART-RACE cDNA amplification kit (CLON-TECH) according to the manufacturer's protocol. Specific primers used for 5Ј-RACE were: antisense 5Ј-RACE-A1, 5Ј-TTT-ATTCGTGTCCTCCAAAGGCGTCC-3Ј; and antisense nested 5Ј-RACE-A2, 5Ј-AGTTTCCATACCCAAAGGCTCAGTGC-3Ј. Similarly, specific primers used for 3Ј-RACE were: sense 3Ј-RACE-S1, 5Ј-TCATCCAGGGAGGCAAACACCGAGAT-3Ј; and sense nested 3Ј-RACE-S2, CAGCGTTGAGGACAAT-GGAGCCAGTG-3Ј.
Zebra fish NRP1 cDNA. A cDNA containing the putative zNRP1 ORF was generated by reverse transcription-PCR by using forward and reverse primers that bind zNRP1 cDNA in the 5Ј-untranslated region and 3Ј-untranslated region regions, respectively. The forward primer sequence was: zNRP1-LDS1: 5Ј-ATTACTCGTCTATTTCGCGGAACTGC-3Ј. The reverse primer sequence was: zNRP1-LDAS1: 5Ј-ACAGAGCCTT-GTCCTCCTCCAATC-3Ј. Reverse transcription-PCR by using cDNA generated from 24 hpf embryo total RNA as a template produced a single predicted 3.2-kb band that was directly cloned into the pGEM-T-easy vector (Promega) and the expression vector pCR3.1 (Invitrogen) to generate pGEM-T-easy-zNRP1 and pCR3.1-zNRP1, respectively. Both constructs were fully sequenced and compared to ensure sequence fidelity.
Western Blot and VEGF Binding. Transfections. Porcine aortic endothelial cells (6) were transfected with 1 g of control vector (pCR 3.1) or pCR3.1-zNRP1 at Ϸ50% confluence by using the FuGene 6 transfection reagent (Roche Molecular Biochemicals) following the manufacturer's instructions.
Western blot. Cells (one 6-cm dish) and embryos (15 dechorionated 24 hpf embryos͞sample) were lysed, incubated with Con A Sepharose beads, and analyzed by Western blot as described (21) . NRP1 (130 kDa) was detected with rabbit anti-NRP1 antibody directed against the b2͞c domain of mouse NRP1 obtained from H. Fujisawa (Nagoya, Japan), at 1:2000 dilution, overnight followed by incubation with horseradish peroxidase-conjugated secondary anti-rabbit IgG (1:10,000; Santa Cruz Biotechnology). Blots were developed by using an enhanced chemiluminescence kit (NEN).
VEGF crosslinking. VEGF 165 was radioiodinated (90,000 cpm͞ng) and chemically cross-linked to porcine aortic endothelial cells with 200 M disuccinimidyl suberate as described (6, 22) . Cross-linked lysates were analyzed by 7.5% SDS͞PAGE, and complexes containing 125 I-VEGF 165 were visualized by autoradiography.
Whole-Mount in Situ Hybridization. Expression of znrp1 was detected by whole mount in situ hybridization as described (23) . After the occurrence of a color reaction with alkaline phosphatase substrates, the embryos were mounted in glycerol and photographed. For embryos that were flat-mounted, the yolk was removed and the embryo flattened under a bridged coverslip for photography.
In Vitro Transcription and Translation. In vitro transcription and translation of zNRP1 was performed by using the TNT Quick Coupled Reticulocyte Lysate system (Promega), according to the manufacturer's protocol with the following modifications: in a 25-l reaction, 0.5 g of pCR3.1-zNRP1 and various amounts of morpholino antisense oligos (0, 1 nM-10 M final concentration) were added to the TNT Quick Master Mix that contained all of the required components for in vitro transcription and translation and incubated at 30°C for 90 min. Five microliters from the reaction mix were resolved by 7.5% SDS͞PAGE, and S 35 -labeled proteins were visualized by autoradiography.
Morpholinos. Morpholinos were designed with sequences complementary to znrp1 cDNA in a location just upstream to the initiating start codon based on the company's recommendations. The morpholino sequences were: zNRP1 morpholino, 5Ј-GAATCCTGGAGTTCGGAGTGCGGAA-3Ј; zNRP1 4-base mismatch morpholino, 5Ј-GATTCCAGGAGTTCGGACTGC-CGAA-3Ј; and zebrafish VEGF morpholino, 5Ј-GTATCAAATA-AACAACCAAGTTCAT-3Ј. Morpholino antisense oligos were diluted in 5 mM Hepes pH 7.4. Morpholino solutions (150 pl) were injected into the blastomere of each embryo at the 1-4 cell stage. Four-base mismatch morpholinos and inert standard morpholinos, which have no effect on zebrafish development, were used as controls. Inert standard morpholino (0.125 mM, 5Ј-CCTCTTAC-CTCAGTTACAATTTATA-3Ј) tagged with fluorescein at the 3Ј-end was mixed into each sample to monitor success of injection and even distribution of morpholino in the embryos.
Kinase Inhibitors. The VEGFR-2 tyrosine kinase inhibitor PTK787͞ZK 222584 (24) was kindly obtained from Novartis Pharma AG. Dechorionated zebrafish embryos were soaked in 3 ml of fish medium containing various concentrations of kinase inhibitor in 6-well plates.
Imaging. Zebrafish embryos were visualized with an Olympus SZX12 stereomicroscope and photographed by using an Olympus DP11 digital camera. To visualize blood vessels, microangiography was performed as described (19) with the following modifications: FITC-Dextran (Sigma) was solubilized in 75 mM NaCl solution and injected into the sinus venosa. For fluorescent microscopy, a FITC filter was used. For visualization of blood flow, zebrafish were magnified (ϫ40) by using transmitted light on a Nikon Diaphot 300 inverted microscope and serial time-lapse images were collected by using a Hamamatsu (Middlesex, NJ) CCD digital camera (model 4742-95). The mean image intensity for these images was calculated on a pixel-by-pixel basis by using the IPLAB RATIOPLUS program (Scanalytics). Images depicting the variance from the mean were produced to display areas of movement, which corresponded to blood flow. These images were then pseudocolored within an intensity window to show areas of blood flow.
Results

Isolation of a Zebrafish nrp1 cDNA.
To analyze the function of NRP during development, the zebrafish ortholog of nrp (znrp) was isolated by using degenerate primers, which were designed based on highly conserved human, mouse, rat, and chicken NRP1 amino acid sequences. The predicted zNRP ORF encodes a 923-aa protein, the same size as human NRP1. zNRP contains a 19-aa putative signal peptide, a relatively large 859-aa extracellular domain, a transmembrane domain, and a relatively short 40-aa cytoplasmic domain (not shown). Overall, zNRP is Ϸ64% identical to human and rat NRP1 and Ϸ45% identical to human NRP2. Based on these amino acid identities and the greater homology to mammalian nrp1, we have designated the znrp gene as znrp1.
Whole-Mount in Situ Hybridization of zNRP. The expression pattern of znrp1 during embryonic and early larval development was examined by whole mount in situ hybridization (Fig. 1) . Maternal transcripts for znrp1 were ubiquitously distributed in the embryo until the early gastrula stage but by the end of gastrulation became localized to the yolk syncytial layer (not shown). During somitogenesis stages, znrp1 showed a dynamic expression pattern with transcripts being detected in the hatching gland, notochord, central nervous system, cranial neural crest cells, somites, and lateral plate mesoderm ( Fig. 1 A and data not shown) . By 22 somites (Fig. 1B) , new sites of znrp1 expression included angioblasts in the tail, gut endoderm, motoneurons, and hypochord. At this stage, transcripts of znrp1 were restricted to the ventromedial regions of the somites. Between 24 and 36 hpf, the expression of znrp1 within the vascular system expanded to include the endothelium of the major vessels in the trunk and tail (data not shown). At 48 hpf ( Fig. 1 C and D) , elaborate staining for znrp1 was found in the brain, eyes, pectoral fin buds (Fig. 1C  Inset) , trunk, and tail vasculature ( Fig. 1 C and D) , as well as persisting in the gut endoderm (Fig. 1C) . Within the trunk and tail vasculature, znrp1 transcripts were detected in the endothelium of the dorsal aorta and posterior cardinal vein, the caudal vein plexus, and the intersegmental vessels in the tail (Fig. 1D ).
zNRP1 Is a Functional Isoform-Specific Receptor for VEGF165 and Not VEGF 121. To detect zNRP1 protein, Western blot was carried out by using an Ab directed against the extracellular domains of mouse NRP1. A 130-to 140-kDa zNRP1 protein was detected in EC transfected with znrp1 cDNA (Fig. 2A, lane 2) and in lysates prepared from 24-hpf wild-type zebrafish embryos (Fig. 2 A, lane  3) . Furthermore, zNRP1 was shown to be a functional receptor. Human 125 I-VEGF 165 cross-linked EC transfected with znrp1 cDNA (Fig. 2B, lane 2) , but not vector alone (Fig. 2B, lane 1) , (Fig. 2B, lane 4) , consistent with the known isoform specificity of VEGF-NRP interactions (6).
Specific Morpholino Oligos Inhibit zNRP1 in Vitro Translation. Antisense morpholino oligos (morpholinos) are specific inhibitors of translation that act by binding to complementary sequences on mRNA and inhibiting access by ribosomes (17) . Anti-zNRP1 morpholinos and control morpholinos with 4 of the 26 bases mutated (4-base mismatch) were synthesized. The potency and specificity of zNRP1 morpholinos were tested in an in vitro transcription and translation system. The zNRP1 morpholino oligos inhibited protein translation in a dose-dependent manner (Fig. 2C, lanes 2-4) . Quantitation by densitometric analysis demonstrated that 1 and 10 M morpholino inhibited zNRP1 translation by Ϸ75% and 87%, respectively. On the other hand, the inhibition by the control 4-base mismatch morpholinos was negligible, even at 10 M (Fig. 2C, lanes 5-7) .
Inhibition of zNRP1 Synthesis in Vivo Results in Vascular Defects.
Zebrafish embryos were microinjected with 0.1 mM zNRP1 morpholinos at the 1-4 cell stage and examined for vascular defects at 24-48 hpf. The vascular defects included an accumulation of blood cells in the tail, short-circuited blood flow and lack of circulation in intersegmental vessels. Approximately 65-70% of the 62 zNRP1 morpholino-injected embryos tested (Fig. 3A, lane 3) had vascular defects as compared to 7% of the embryos injected with the 4-base mismatch control (Fig. 3A, lane  4) at the same concentrations. As further controls, uninjected embryos (Fig. 3A, lane 1) or embryos injected with an inert standard morpholino (Fig. 3A, lane 2) were not affected. Serial photomicrographs were used to produce images depicting the variance from the mean, thereby effectively depicting only the areas of active blood flow (Fig. 3 B-D) . Embryos injected with 4-base mismatch control morpholinos (Fig. 3B) had normal blood cell circulation via axial (e.g., dorsal aorta, posterior cardinal vein) vessels, intersegmental vessels, and the dorsal anastamosing longitudinal vessels (DLAV). On the other hand, in embryos treated with zNRP1 morpholinos, the vascular bed appeared short-circuited and circulation was blocked in the tail beginning at Ϸ36 hpf (Fig. 3 C and D) . In some cases, abnormal connections (fistulas) were formed between the artery and vein, which prematurely returned blood circulation back to the heart (Fig. 3C ). Blood cells accumulated posterior to the abnormal fistulas. There was essentially no circulation in intersegmental vessels and the DLAV.
Blood vessel circulation also was analyzed by microangiography (Fig. 4) . Embryos were injected with morpholinos and FITC-dextran was injected into the circulation through the cardinal veins of these embryos at Ϸ56 hpf to visualize blood vessels directly. At a concentration of 0.1 mM morpholino, approximately one-half of the embryos had defects including diminished circulation in the intersegmental vessels, in the DLAV and in the caudal vein plexus (Fig. 4B) . On the other hand, circulation in the trunk axial vessels appeared normal. Preferential inhibitory effects on small but not large blood vessels occurred at higher morpholino concentrations as well. In contrast, all of the embryos injected with 4-base mismatch control morpholinos had normal blood vessels (Fig. 4A). zNRP1 Mediates VEGF-Dependent Angiogenesis. Zebrafish were treated with a VEGFR-2 kinase inhibitor at 24 hpf, and circulation through the blood vessels was visualized by injection of FITC-dextran into the cardinal vein at 56 hpf. As was the case with zNRP1 morpholino treatment, there was a preferential inhibitory effect on intersegmental vessel͞DLAV circulation compared to trunk vessels (Fig. 4C ). EGFR and PDGFR kinase inhibitors did not induce an abnormal vascular phenotype (data not shown). These results suggested that zNRP1 knockdown might affect VEGF activity. To examine this possibility, zebrafish were coinjected with anti-zNRP1 and anti-VEGF morpholinos. It has previously been shown that antisense VEGF morpholinos inhibited blood vessel formation in zebrafish embryos in a dose-dependent manner (19) . In confirmation, 1 mM VEGF morpholino inhibited both axial vessels and intersegmental vessel development (Fig. 4D) . A lower concentration of VEGF morpholino (0.3 mM) was chosen which did not have any significant effect on blood vessel circulation (Fig. 4E) . Of the 22 embryos injected with VEGF morpholino at this concentration, none (0͞22) had defects in trunk axial vessel circulation and only 2͞22 had defects in intersegmental vessel͞DLAV circulation. A concentration of anti-zNRP1 morpholino (0.1 mM) was chosen that had no inhibitory effects on trunk axial vessels (0͞14) and with inhibitory effects on intersegmental vessel and DLAV circulation in one-half of the 14 embryos (Fig. 4B) . However, when embryos were coinjected with both morpholinos, all of the embryos (19͞19) exhibited a total loss of the circulation throughout the trunk, both axial and intersegmental vessels (Fig.  4F) . As a control, there were no vascular defects in the 13 embryos coinjected with zebrafish VEGF morpholino and the zNRP 4-base mismatch morpholino (Fig. 4G) , demonstrating the contribution of zNRP1 to the vascular defects. Together these results suggest that zebrafish VEGF and zNRP1 cooperate in maintaining trunk axial and intersegmental vessel function.
Discussion
NRP1 plays an important role in regulating developmental angiogenesis (12) (13) (14) . It binds VEGF 165 but has no known kinase activity. To understand the mechanisms by which NRP1 regulates angiogenesis, about which little is known, we have analyzed NRP1 function in zebrafish. In this report, we describe the isolation, expression, and functional analysis of the zebrafish ortholog of the nrp1 gene as an isoform-specific receptor for VEGF 165 . Furthermore, we demonstrate that angiogenesis in the zebrafish is mediated by VEGF-zNRP1 interactions in vivo.
zNRP1 is expressed mainly in neuronal and vascular tissues during embryogenesis. During formation of the vascular system, transcripts for znrp1 are first expressed by tail angioblasts toward the end of somitogenesis and then become more widespread to include the endothelium of the major trunk vessels and intersegmental vessels by 48 hpf. To determine zNRP1 function, we used antisense morpholino oligos to inhibit protein synthesis (17) . The knockdown of zNRP1 resulted in several vascular defects. The smaller blood vessels, corresponding to capillaries in particular, were affected. For example, there was diminished circulation in the intersegmental vessels and in the DLAV. Circulation also was diminished in the caudal vein plexus of the posterior tail. On the other hand, circulation via the larger trunk vessels-e.g., the dorsal aorta was not inhibited. There were some cases where circulation was short-circuited in the tail as a result of abnormal artery-vein connections, consistent with lack of a functional caudal vein plexus that normally connects the dorsal aorta and axial vein.
What are the possible explanations for the vascular defects seen in the zNRP1-deficient embryos? Cardiac contractility and size appeared to be normal; no obstruction of the aortic outflow tract was observed; and circulation via the trunk axial vessels was normal as analyzed by FITC dextran microangiography and by observing red blood cells circulating at a normal rate. Furthermore, the axial vessels were not affected, even though the morpholinos were administered at the 1-2 cell stage, before development of the axial vessels. On the other hand, zNRP1 deficiency resulted in a defect in the intersegmental vessels in which circulation was diminished. The nature of the defect is not clear. In situ hybridization analysis indicated that VEGFR-2 was expressed in the intersegmental vessel EC, suggesting that the EC are viable and that intact EC tubes might be present. However, even if tubes were present, they must be immature and nonfunctional because there was no blood flow via the intersegmental vessels whereas there was normal blood flow in the axial vessels. The differential effects of zNRP1 deficiency on small vs. large vessels may occur because they are products of different processes. The larger axial arteries and veins arise from the process of vasculogenesis, which involves the differentiation of precursor cells into EC, a process that occurs early in zebrafish development within hours. On the other hand, the small blood vessels are generated later by the process of angiogenesis, which represents sprouting and branching from preexisting axial blood vessels. Intersegmental vessels begin to sprout from the preexisting dorsal aorta at Ϸ24 h (25) . Recently, we showed that a double knockout of mouse NRP1 and NRP2 was characterized by lack of blood vessel branching in the yolk sac and diminished small blood vessel sprouting and lack of capillary plexus formation in the embryo (26) , consistent with the zNRP1 morpholino phenotype. Furthermore, it was possible to rescue defective vascular development and angiogenesis in NRP1-deficient mouse embryos and in para-aortic explants prepared from these mice with a dimer of soluble NRP1 (27) . Together, it is plausible that zNRP1 plays a role in sprouting of a functionally mature smaller vessel network that enables circulation to occur through these vessels, but not in development of the larger axial vessels.
That zNRP1 knockdown affects VEGF activity is plausible because zNRP1 binds VEGF 165 . A VEGFR-2 kinase inhibitor administered at 24 hpf when intersegmental vessel sprouting begins, and analyzed at 56 hpf, had a vascular phenotype similar to that of zNRP1 morpholino-treated embryos analyzed at 56 hpf-i.e., circulation was inhibited in intersegmental vessels and the DLAV but not in trunk axial vessels. A similar result by using the same kinase inhibitor, PTK787͞ZK 222584, was recently reported (28) . These results suggested that loss of zNRP1 synthesis had similar effects on zebrafish intersegmental vasculature as did loss of VEGF activity mediated by VEGFR-2.
To examine the possibility that NRP1 and VEGF function might be interdependent, we analyzed the effects of coinjecting NRP1 morpholinos and VEGF morpholinos at concentrations that individually did not significantly inhibit blood vessel development. The result was a complete impairment in both trunk axial vessel and intersegmental vessel circulation. Thus, it appears that the ability of VEGF to mediate zebrafish embryonic blood vessel development depends on cooperation with zNRP1.
We propose that in the presence of normal VEGF levels, the formation of intersegmental vessels require zNRP1 whereas the larger axial vessels are formed even if zNRP1 is not available. However, when VEGF availability is reduced, the formation of the trunk axial vessels is zNRP1-dependent. Previously, we demonstrated in vitro that NRP1 was a coreceptor for VEGFR-2 in EC that enhanced VEGF 165 binding to VEGFR-2 (6). A possible mechanism in zebrafish is that the expression of zNRP1 lowers the concentration of VEGF required for activating VEGFR-2 to promote vasculogenesis and angiogenesis. The concentration dependence of VEGF in vivo is well established (7, 8) . The possibility that zNRP1 deficiency might affect semaphorin activity has not been tested.
In summary, our studies provide an in vivo physiological demonstration that zebrafish VEGF activity is NRP1 dependent. The results also provide a mechanism by which NRP1 promotes developmental angiogenesis through its interaction with VEGF 165 . 
